Israel - heprea - Ministry of Health

abbvie biopharmaceuticals ltd, israel - palivizumab 50 mg - powder for solution for injection - palivizumab - is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (rsv). safety and efficacy were established in infants with bronchopulmonary dysplasia (bpd) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Israel - heprea - Ministry of Health

glaxo smith kline (israel) ltd - live attenuated measles virus; live attenuated mumps virus; live attenuated rubella virus - אבקה וממס להכנת תמיסה להזרקה - live attenuated mumps virus 10^3.7 ccid50; live attenuated rubella virus 10^3.0 ccid50; live attenuated measles virus 10^3.0 ccid50 - rubella, combinations with mumps, live attenuated - rubella, combinations with mumps, live attenuated - priorix is indicated for active immunisation of children from the age of 9 months or older, adolescents and adults against measles, mumps and rubella.

Israel - heprea - Ministry of Health

sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Israel - heprea - Ministry of Health

abic marketing ltd, israel - doxorubicin hydrochloride - תרכיז להכנת תמיסה לאינפוזיה - doxorubicin hydrochloride 2 mg/ml - doxorubicin - doxorubicin - to produce regression in disseminated neoplastic conditions such as: - acute lymphoblastic leukemia, - acute myeloblastic leukemia, - wilms' tumor neuroblastoma, - soft tissue and bone sarcomas, - breast carcinoma, - lymphomas of both hodgkin's and non-hodgkin's types, - bronchogenic carcinoma in which the small cell histologic type is the most responsive compared to other cell types, - gastric carcinoma.

Israel - heprea - Ministry of Health

novartis israel ltd - doxorubicin hydrochloride - solution for infusion - doxorubicin hydrochloride 2 mg/ml - doxorubicin - doxorubicin - soft tissue and bone sarcomas, hodgkin's and non-hodgkin's lymphoma, acute lymphoblastic leukemia, acute myeloblastic leukemia, wilms` tumor, carcinomas of the thyroid, breast, ovary, bladder, small cell bronchogenic carcinoma and neuroblastoma.

Israel - heprea - Ministry of Health

rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.

Israel - heprea - Ministry of Health

rafa laboratories ltd - cetalkonium chloride; choline salicylate - ג'ל - cetalkonium chloride 0.01 %w/w; choline salicylate 8.7 %w/w - choline salicylate - choline salicylate - as an antiseptic and local pain reliever for mouth ulcers, teething pain, denture irritation, and cold sores.

Israel - heprea - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 30 mg - pyridostigmine - pyridostigmine - pyridostigmine belongs to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.

Israel - heprea - Ministry of Health

megapharm ltd - pyridostigmine bromide - דרז'ה - pyridostigmine bromide 60.0 mg - pyridostigmine - pyridostigmine - treatment of myasthenia gravis.

Israel - heprea - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - טבליה - pyridostigmine bromide 60 mg - pyridostigmine - pyridostigmine - pyridostigmine belons to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.